Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: A4I968
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 381 | 385 | PF00656 | 0.497 |
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.467 |
CLV_PCSK_KEX2_1 | 117 | 119 | PF00082 | 0.467 |
CLV_PCSK_KEX2_1 | 40 | 42 | PF00082 | 0.659 |
CLV_PCSK_PC1ET2_1 | 40 | 42 | PF00082 | 0.659 |
CLV_PCSK_PC7_1 | 36 | 42 | PF00082 | 0.632 |
CLV_PCSK_SKI1_1 | 195 | 199 | PF00082 | 0.330 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.643 |
CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.623 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.643 |
DEG_APCC_DBOX_1 | 27 | 35 | PF00400 | 0.605 |
DOC_CYCLIN_RxL_1 | 2 | 10 | PF00134 | 0.509 |
DOC_CYCLIN_yCln2_LP_2 | 89 | 95 | PF00134 | 0.420 |
DOC_MAPK_MEF2A_6 | 323 | 332 | PF00069 | 0.336 |
DOC_MAPK_MEF2A_6 | 85 | 93 | PF00069 | 0.404 |
DOC_PP1_RVXF_1 | 206 | 213 | PF00149 | 0.520 |
DOC_PP2B_LxvP_1 | 89 | 92 | PF13499 | 0.425 |
DOC_PP4_FxxP_1 | 95 | 98 | PF00568 | 0.454 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.622 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.510 |
DOC_USP7_MATH_1 | 369 | 373 | PF00917 | 0.457 |
DOC_USP7_MATH_2 | 63 | 69 | PF00917 | 0.728 |
DOC_WW_Pin1_4 | 133 | 138 | PF00397 | 0.680 |
LIG_14-3-3_CanoR_1 | 157 | 163 | PF00244 | 0.501 |
LIG_14-3-3_CanoR_1 | 5 | 15 | PF00244 | 0.591 |
LIG_Actin_WH2_2 | 283 | 301 | PF00022 | 0.455 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.693 |
LIG_BRCT_BRCA1_1 | 176 | 180 | PF00533 | 0.475 |
LIG_deltaCOP1_diTrp_1 | 188 | 194 | PF00928 | 0.522 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.646 |
LIG_FHA_1 | 285 | 291 | PF00498 | 0.335 |
LIG_FHA_1 | 394 | 400 | PF00498 | 0.630 |
LIG_FHA_2 | 142 | 148 | PF00498 | 0.614 |
LIG_GBD_Chelix_1 | 115 | 123 | PF00786 | 0.508 |
LIG_LIR_Apic_2 | 132 | 138 | PF02991 | 0.644 |
LIG_LIR_Apic_2 | 99 | 104 | PF02991 | 0.475 |
LIG_LIR_Gen_1 | 256 | 265 | PF02991 | 0.430 |
LIG_LIR_Gen_1 | 335 | 342 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 256 | 260 | PF02991 | 0.412 |
LIG_LIR_Nem_3 | 335 | 340 | PF02991 | 0.328 |
LIG_NBox_RRM_1 | 194 | 204 | PF00076 | 0.577 |
LIG_NRBOX | 327 | 333 | PF00104 | 0.450 |
LIG_SH2_CRK | 101 | 105 | PF00017 | 0.553 |
LIG_SH2_CRK | 135 | 139 | PF00017 | 0.656 |
LIG_SH2_CRK | 15 | 19 | PF00017 | 0.539 |
LIG_SH2_CRK | 257 | 261 | PF00017 | 0.409 |
LIG_SH2_CRK | 337 | 341 | PF00017 | 0.352 |
LIG_SH2_GRB2like | 47 | 50 | PF00017 | 0.750 |
LIG_SH2_NCK_1 | 15 | 19 | PF00017 | 0.647 |
LIG_SH2_SRC | 47 | 50 | PF00017 | 0.750 |
LIG_SH2_STAP1 | 244 | 248 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.687 |
LIG_SH2_STAT5 | 143 | 146 | PF00017 | 0.599 |
LIG_SH3_3 | 57 | 63 | PF00018 | 0.611 |
LIG_SUMO_SIM_anti_2 | 72 | 78 | PF11976 | 0.641 |
LIG_SUMO_SIM_par_1 | 329 | 335 | PF11976 | 0.336 |
LIG_SUMO_SIM_par_1 | 72 | 78 | PF11976 | 0.651 |
LIG_TRAF2_1 | 105 | 108 | PF00917 | 0.530 |
LIG_TRAF2_1 | 97 | 100 | PF00917 | 0.497 |
LIG_TYR_ITIM | 255 | 260 | PF00017 | 0.375 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.636 |
MOD_CK1_1 | 324 | 330 | PF00069 | 0.418 |
MOD_CK1_1 | 398 | 404 | PF00069 | 0.627 |
MOD_CK2_1 | 141 | 147 | PF00069 | 0.593 |
MOD_CK2_1 | 258 | 264 | PF00069 | 0.426 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.665 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.412 |
MOD_GlcNHglycan | 322 | 326 | PF01048 | 0.354 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.542 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.424 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.593 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.594 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.444 |
MOD_N-GLC_1 | 165 | 170 | PF02516 | 0.490 |
MOD_N-GLC_1 | 21 | 26 | PF02516 | 0.632 |
MOD_N-GLC_1 | 48 | 53 | PF02516 | 0.723 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.361 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.476 |
MOD_NEK2_1 | 253 | 258 | PF00069 | 0.300 |
MOD_NEK2_1 | 284 | 289 | PF00069 | 0.433 |
MOD_NEK2_1 | 393 | 398 | PF00069 | 0.604 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.631 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.612 |
MOD_NEK2_2 | 158 | 163 | PF00069 | 0.558 |
MOD_NEK2_2 | 189 | 194 | PF00069 | 0.494 |
MOD_NEK2_2 | 294 | 299 | PF00069 | 0.450 |
MOD_PIKK_1 | 401 | 407 | PF00454 | 0.627 |
MOD_PIKK_1 | 48 | 54 | PF00454 | 0.718 |
MOD_PK_1 | 395 | 401 | PF00069 | 0.646 |
MOD_PKA_2 | 277 | 283 | PF00069 | 0.542 |
MOD_PKA_2 | 369 | 375 | PF00069 | 0.409 |
MOD_PKA_2 | 382 | 388 | PF00069 | 0.409 |
MOD_PKA_2 | 84 | 90 | PF00069 | 0.502 |
MOD_Plk_1 | 141 | 147 | PF00069 | 0.523 |
MOD_Plk_1 | 21 | 27 | PF00069 | 0.620 |
MOD_Plk_1 | 280 | 286 | PF00069 | 0.451 |
MOD_Plk_4 | 126 | 132 | PF00069 | 0.630 |
MOD_Plk_4 | 21 | 27 | PF00069 | 0.618 |
MOD_Plk_4 | 227 | 233 | PF00069 | 0.423 |
MOD_Plk_4 | 280 | 286 | PF00069 | 0.424 |
MOD_Plk_4 | 335 | 341 | PF00069 | 0.336 |
MOD_Plk_4 | 382 | 388 | PF00069 | 0.585 |
MOD_Plk_4 | 398 | 404 | PF00069 | 0.551 |
MOD_Plk_4 | 70 | 76 | PF00069 | 0.639 |
MOD_ProDKin_1 | 133 | 139 | PF00069 | 0.684 |
TRG_DiLeu_BaEn_1 | 335 | 340 | PF01217 | 0.352 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.547 |
TRG_ENDOCYTIC_2 | 184 | 187 | PF00928 | 0.586 |
TRG_ENDOCYTIC_2 | 257 | 260 | PF00928 | 0.384 |
TRG_ENDOCYTIC_2 | 337 | 340 | PF00928 | 0.328 |
TRG_ER_diArg_1 | 117 | 119 | PF00400 | 0.467 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P843 | Leptomonas seymouri | 80% | 100% |
A0A0S4JIY4 | Bodo saltans | 46% | 85% |
A0A0S4JLP5 | Bodo saltans | 24% | 83% |
A0A1X0P137 | Trypanosomatidae | 54% | 94% |
A0A3Q8IDU0 | Leishmania donovani | 100% | 100% |
A0A422MV93 | Trypanosoma rangeli | 55% | 88% |
A4HLN3 | Leishmania braziliensis | 91% | 100% |
C9ZIW4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 87% |
E9B409 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
Q4Q415 | Leishmania major | 97% | 100% |
V5BLY0 | Trypanosoma cruzi | 55% | 93% |